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are said to enjoy superior aging. Second, the majority of
individuals experience a decline from this hypothetical
peak but are said to show age-appropriate cognitive
functioning because their performance remains within
the range of same-age peers. Third, some individuals
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complain of forgetfulness and perform significantly
worse than their same-age peers without necessarily
Alzheimer's disease (AD) is a predominantly amnestic experiencing a disruption of daily living activities. They
dementia that arises on a neuropathological back- are said to be in a state of senescent forgetfulness or
ground of amyloid plaques (AP) and neurofibrillary tan- mild cognitive impairment. (Petersen et al., 1999). Fourth,
gles (NFT). A loss of neurons, synapses, and cortical in still other individuals, the deterioration reaches a level
cholinergic innervation constitutes additional features of severity that interferes with daily living activities and
of the disease. Numerous investigations have attempted that becomes consistent with the diagnostic criteria for
to isolate the one aspect of the neuropathology that is dementia. Each of these stages is associated with a
most closely associated with the cognitive deficits. Such characteristic pattern of NFT distribution.
claims have been made for the AP (Cummings et al.,
1996), NFT (Arriagada et al., 1992), neuronal loss (GoÂ - The NFT of AD
mez-Isla et al., 1997), synaptic loss (Terry et al., 1991), The NFT are formed by insoluble intracellular polymers
and cholinergic depletion (Francis et al., 1985). The inter- of hyperphosphorylated tau, the less phosphorylated
actions among these components have been investi- forms of which stabilize the microtubules of the axonal
gated intensively in an attempt to identify a pivotal prime cytoskeleton (Trojanowski et al., 1993). The NFT are
mover for the disease process. Despite numerous at- thought to interfere with cytoskeletal integrity. They in-
tempts, however, a unitary theory that can account for duce neuronal dysfunction and, eventually, the destruc-
all the clinical and neuropathological features has failed tion of synapses and neurons. Nearly all individuals
to emerge. This review proposes that a perturbation of above the age of 60 have at least a few NFT in the brain
neuroplasticity may provide the core of such a unifying (Braak and Braak, 1996). Whenever a brain contains
theory. very few NFT, they are always confined to limbic and
paralimbic structures such as the hippocampus, the nu-
The Memory Loss of AD and Its Continuity with Mild cleus basalis of Meynert, the amygdala, and the entorhi-
Cognitive Impairment and Aging nal±transentorhinal cortex (Figure 1). These parts of the
AD causes a severe memory loss accompanied by addi- brain play critical roles in the neural control of memory
tional but usually less prominent impairments of atten- function. This initial low limbic stage of NFT distribution
tion, language, perception, reasoning, and comport- may provide a crucial anatomical substrate for the com-
ment (Price et al., 1993; Morris et al., 1996). A state of mon and relatively selective memory impairments asso-
dementia becomes identified when these deficits under- ciated with aging. The next level of NFT density can be
mine the capacity for independent living. The onset of designated the high limbic stage: the NFT become more
the dementia in AD is preceded by a transitional ªpreclin- numerous within limbic areas, they start to form clusters
icalº period of many years during which relatively iso- in the immediately adjacent fusiform and inferotemporal
lated memory difficulties exceed those expected on the gyri, and they appear in additional paralimbic areas such
basis of normal aging, without, however, becoming se- as the temporal pole, insula, orbitofrontal cortex, and
vere enough to interfere with daily living activities (Linn the parolfactory gyrus. This stage of NFT distribution
et al., 1995; Fox et al., 1998). Even ªnormalº aging does may be associated with the states of mild cognitive
not necessarily imply that memory function has re- impairment, senescent forgetfulness and preclinical AD
mained intact (Small et al., 1999). In a delayed recall (Delacourte et al., 1999). Only after reaching relatively
test (Visual Reproduction 2 of the Wechsler Memory high densities within limbic, paralimbic, and inferotem-
Scale±Revised), for example, average performance for poral areas do the NFT eventually emerge and then
30 year olds corresponds to a score of 31 or better, accumulate in prefrontal and parietotemporal associa-
whereas average performance for 70 year olds corre- tion areas involved in the neural control of language,
sponds to a score of 15. Thus, normal scores at the age attention, and perception (Braak and Braak, 1996; Mor-
of 70 do not indicate a preservation of memory function. rison and Hof, 1997; Delacourte et al., 1999). The corre-
They only indicate that the putative decline has been sponding low and high neocortical stages of NFT density
average for the group of individuals at the same age. are associated with the mild and then severe dementia of
These considerations suggest that four different levels AD during which cognitive functions other than memory
of memory function can be identified during the course also become compromised (Arnold et al., 1991; Arria-
of an individual's lifetime. First, a stage of peak perfor- gada et al., 1992; Braak and Braak, 1996; GoÂ mez-Isla
mance is reached at some point in the life span. It may et al., 1996; Giannakopoulos et al., 1997; Hyman and
be preserved during senescence by rare individuals who Trojanowski, 1997; Morrison and Hof, 1997). The neuro-
pathological criterion for a definitive diagnosis of AD is
reached only when NFT clusters emerge in association*E-mail: mmesulam@nwu.edu.
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Figure 1. The Progression of NFT in Time and
Space and Their Relationship to the Clinical
State
One, two, three, and four plus signs refer to
low, medium, high, and very high densities of
NFT, respectively. The low limbic stage corre-
sponds stages I and II of Braak and Braak
(1996), the high limbic stage to their stages
III and IV, the low neocortical stage to their
stage V, and the high neocortical stage to
their stage VI.
neocortex (National Institute on Aging, 1997). In keeping (Selkoe, 1994; Yankner, 1996). In at least 95% of patients
with AD, onset occurs in late adulthood, usually afterwith the relative preservation of sensation and motility
in AD, primary sensory±motor areas contain relatively the age of 65. In a small minority of cases, the disease
has an autosomal dominant pattern of inheritance andfew NFT even in patients with high densities of limbic
and neocortical tangles (Figure 1). The generality of this can start much earlier. The mutations that cause the
dominantly inherited forms of AD are located on chromo-tight correspondence between NFT distribution and
mental state has been challenged by reports of rare somes 21, 14, and 1.
There is no known genetic linkage between AD andpatients who were not demented despite the presence
of NFT at the high neocortical stage (Davis et al., 1999). tau-processing abnormalities that might lead to NFT
formation. In contrast, an impressive body of evidenceOne possible explanation is that these patients might
have experienced a considerable decline of mental func- based on genetics has implicated abnormal amyloid
processing in the causation of AD. This evidence cantion from an exceptionally high baseline without neces-
sarily fulfilling the criteria for dementia. Alternatively, be summarized under six categories. First, mutations in
the AbPP gene (chromosome 21) are sufficient to causethey may have had an unusual neuronal reserve capacity
that may have compensated for the impact of the NFT- early-onset AD. Second, all AD-causing mutations of
AbPP, presenilin 1 (PS1 on chromosome 14), and pre-related neurodegeneration.
The stages of distribution shown in Figure 1 suggest senilin 2 (PS2 on chromosome 1) lead to the proportion-
ally greater production of the more neurotoxic ªlongºthat the vulnerability to NFT formation is highest in the
limbic areas of the medial temporal lobe. This vulnerabil- form of Ab. Third, trisomy 21 (Down's syndrome), which
leads to an overproduction of AbPP and Ab, invariablyity appears to become transferred along monosynaptic
connections from limbic to paralimbic areas, then from leads to the early emergence of AD neuropathology.
Fourth, the e4 allele of apolipoprotein E (apoE), a majorparalimbic areas to association neocortex, and only ter-
minally from association neocortex to primary sensory± risk factor for sporadic AD, promotes the precipitation
of Ab into insoluble plaques. Fifth, at least in vitro, Abmotor areas. The putative role of axonal connections is
highlighted by the fact that subcortical nuclei monosyn- can kill neurons and can induce the phosphorylation of
tau. Sixth, the overexpression of AD-causing mutantsaptically interconnected with the cerebral cortex (such
as the hypothalamus, brainstem raphe, and nucleus lo- of AbPP in transgenic mice induces the deposition of
amyloid plaques, local damage to neuronal processes,cus coeruleus) develop numerous NFT, whereas those
with no cortical connections (such as the globus pal- tau phosphorylation, neuronal loss, and perhaps also
behavioral deficits (Selkoe, 1994; Olichney et al., 1996;lidus) do not. The interval between the initial appearance
of the NFT in limbic areas and their widespread neocorti- Yankner, 1996; Duff, 1997; Hardy, 1997; Calhoun et al.,
1998).cal distribution in the terminal stages of the dementia
may be as long as 50 years (Braak and Braak, 1996). Despite all this supporting evidence, however, an am-
yloid-based theory of AD pathogenesis faces major
challenges: in contrast to NFT, plaques display substan-Amyloid and AD
The AP accumulate in the extracellular space. They con- tial interindividual variations of distribution, but these
variations have no known relationship to the patterntain insoluble fibrils of the amyloid b (Ab) fragment of a
much larger precursor protein (AbPP). The AbPP is a of cognitive deficits; although the initial memory loss
indicates the presence of early limbic dysfunction, thetransmembrane protein normally processed by three
proteases known as the a, b, and g secretases. The a initial plaques tend to appear in association neocortex
rather than limbic areas; in unusual clinical presenta-secretase splits the AbPP in the middle of the Ab domain
and precludes the release of the plaque-forming Ab frag- tions of AD, the NFT display distribution patterns that
fit the expected anatomical substrate of the neuropsy-ment, whereas the b and g secretases yield moieties
that contain the full Ab fragment. Depending on the site chological deficit, whereas the AP do not; extensive
neocortical plaque deposits can be seen in nonde-of g secretase cleavage, the resultant Ab fragment can
be ªshortº (Ab1-40) or ªlongº (Ab1-42, 43). The long form mented elderly individuals; the correlation between
plaque densities and dementia is usually poor; none ofof Ab is more insoluble and potentially more neurotoxic
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the transgenic animals overexpressing the AD-causing pathway induce intact neurons to sprout collateral
mutations of AbPP has shown NFT formation; and there branches so that they can occupy the denuded synaptic
is no correlation between local densities of plaques and targets in the molecular layer of the dentate gyrus (Cot-
NFT (Arriagada et al., 1992; Guillozet et al., 1995, Soc. man and Nieto-Sampedro, 1984). In the adult monkey,
Neurosci., abstract; Mackenzie et al., 1996; Giannako- trauma to a forelimb causes a large-scale axonal sprout-
poulos et al., 1997, 1999). ing and lateral expansion of connections within neocorti-
It seems as if the Ab plaques appear at the wrong cal somatosensory areas, presumably in response to
time and in the wrong places with respect to the clinical the loss of the afferent input from the injured limb (Flor-
dementia, and there is little evidence that they cause ence et al., 1998). Neuronal death may also induce a
the NFT. One potential resolution to this dilemma may compensatory increase of dendritic branching among
lie in the assumption that amyloid exerts its initial influ- residual neurons at that site, presumably so that the
ence in some mobile, circulating form rather than at the synaptic inputs that have lost their original targets can
sites of plaque deposits (Lambert et al., 1998). However, be accommodated (Agnati et al., 1992).
such an approach would still need to explain how a The process of reactive synaptogenesis may be of
circulating factor can generate the very specific tempo- vital importance for replacing terminals that succumb
ral and spatial pattern of NFT distribution and the spe- to physiological attrition. The presence of such attrition
cific clinical pattern of the dementia. was demonstrated in the ciliary muscle of the monkey
where the half-life of synapse turnover was estimated
Plasticity of the Adult Brain and Its to be around 18 days (Cotman and Nieto-Sampedro,
Differential Distribution 1984). There are z7±8 3 108 synapses in the dentate
The genetics of AD favor a pathogenic mechanism re- gyrus of the rat alone (Calhoun et al., 1996). The number
volving around amyloid deposition, whereas the clinico- of synapses in the human cerebral cortex is undoubtedly
pathological correlations favor a disease based on NFT. many orders of magnitude higher, and these synapses
Although numerous mechanisms have been proposed are probably also subject to turnover and structural up-
for reconciling these two aspects of AD, none has ade- keep. Even if the recycling rate is much slower in the
quately linked the amyloid deposits to the spatial and human CNS than in the ciliary muscle of the monkey, the
temporal patterns of neurofibrillary degeneration. One immense number of synapses suggests that synapse
solution to this dilemma is based on the assumption turnover and upkeep are likely to constitute major activi-
that these two markers of AD are independent manifes- ties of the brain.
tations of a common underlying phenomenon. This re- Conceptually, these plasticity-related phenomena can
view suggests that a prolonged perturbation of neural be divided into downstream processes at the level of
plasticity may represent such a common denominator. axons, synapses, and dendrites and upstream regula-
The relationship of plasticity to AD has been discussed tory processes at the level of the neuronal perikaryon.
in several contexts. It has been suggested that AD is The regulation of neuroplasticity is likely to involve sig-
characterized by a loss of plasticity (Buell and Coleman, nals (such as growth factors) transmitted anterogradely
1979), that it leads to aberrant plasticity (Scheibel and (in the downstream direction) from the perikaryon to
Tomiyasu, 1978; Masliah et al., 1991), that its pathology dendrites and axonal terminals, and also retrogradely
is most severe in parts of the brain that have the greatest (in the upstream direction) from dendrites, axons, and
plasticity (Phelps, 1990; Arendt et al., 1998), and that it postsynaptic targets to the perikaryon. Some of these
may be caused by maladaptive plasticity (Agnati et al., effects are exerted transsynaptically, and many are likely
1992; Neill, 1995). Each of these relationships appears to be mediated by neuroglia (Cotman and Nieto-Sam-
to contribute to the pathogenesis of AD. pedro, 1984; Glanzman et al., 1990; Neill, 1995).
Neuroplasticity is a life-long process that mediates Multiple lines of evidence indicate that the potential
the structural and functional reaction of dendrites, ax-
for neuroplasticity is distributed unevenly in the adult
ons, and synapses to experience, attrition, and injury.
brain so that the propensity for LTP, axonal sprouting,
Experience-induced modifications of synaptic strengths,
dendritic remodeling, and perhaps reactive synaptogen-for example, enable the accumulation of a knowledge
esis is higher in the limbic system than in other parts ofbase that is unique to each individual and provide the
the cerebral cortex (Buell and Coleman, 1979; Neve etcritical substrates for adaptation and individuation. The
al., 1988; Bliss and Collingridge, 1993; Arendt et al.,manifestations of neuroplasticity in the adult CNS include
1995, 1998). Thus, the growth-associated protein GAP-alterations of dendritic ramifications, synaptic remodel-
43, which is a marker for axonal sprouting, is most in-ing, long-term potentiation (LTP), axonal sprouting, neu-
tensely expressed in limbic cortex, especially along therite extension, synaptogenesis, and neurogenesis. Self-
entorhino-hippocampal pathway, suggesting that expe-stimulation, learning new associations, and exposure
rience-dependent remodeling and synaptic turnoverto enriched environments can induce synaptogenesis,
may be highest in this part of the brain (Neve et al.,synaptic remodeling, and neurogenesis in the adult ro-
1988; Lin et al., 1992). In the adult macaque monkey,dent brain (Black et al., 1989; Kempermann et al., 1998;
the expression levels of mRNAs for brain-derived neuro-Klintsova and Greenough, 1999; Rao et al., 1999). Fur-
trophic factor (BDNF) and TrkB are lowest in primarythermore, electrical kindling by perforant pathway stim-
visual cortex, slightly higher in visual association cortex,ulation can induce structural remodeling by increasing
and highest in the hippocampus and entorhinal cortexthe relative number of perforated synapses in the molec-
(Okuno et al., 1999). Furthermore, plasticity-related in-ular layer of the dentate gyrus (Geinisman et al., 1989).
creases in the length and branching of the dendriticPlasticity plays a particularly important role in re-
sponse to injury. Lesions of the entorhino-hippocampal tree during adulthood appear to be most extensive in
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limbic±paralimbic regions such as transentorhinal, ento- specific PS1 mutation and the experimental setting
(Zhang et al., 1998; Kang et al., 1999). Interestingly, therhinal, and hippocampal cortex of the human brain;
maturation of TrkB and its BDNF-inducible autophos-somewhat less pronounced in the association neocortex
phorylation become severely impaired in neurons thatof posterior parietal and prefrontal areas; and undetect-
lack PS1 (Naruse et al., 1998). The AD-causing presenilinable in primary sensory±motor areas (Arendt et al., 1998).
mutations could thus perturb plasticity through twoThis gradient mirrors the temporal and spatial gradient
mechanisms: an interference with the putative plasticity-of NFT densities shown in Figure 1, suggesting that
related functions of PS1 and a shunting of AbPP pro-elevated levels of plasticity-related cellular activity may
cessing toward the longer, more neurotoxic Ab moieties.increase the vulnerability to neurofibrillary degeneration.
ApoE and Plasticity
The e4 allele of apolipoprotein E (apoE) is one of theCauses and Risk Factors of AD Influence Plasticity
most intensely investigated risk factors of AD (Roses,All genetic backgrounds and risk factors associated with
1997). ApoE, encoded by a gene on chromosome 19,AD can potentially influence neuroplasticity.
promotes axonal growth and synaptogenesis, probablyAmyloid and Plasticity
because it regulates the transcellular transport of cho-Full-length AbPP influences cell±substrate interactions
lesterol and phospholipids. Following entorhinal cortexduring neurite extension, promotes the formation and
lesions, for example, the phase of compensatory synap-maintenance of synapses in the CNS, modulates LTP,
togenesis is characterized by a rapid increase of apoEand protects neurons against exitotoxic and oxidative
expression by astrocytes within the denervated molecu-insults (Mucke et al., 1994; Storey et al., 1996; Ishida
lar layer of the dentate gyrus (Poirier, 1994). The impor-et al., 1997; Small, 1998). The soluble/secreted AbPP
tance of apoE for plasticity is supported by experimentsproduct of a secretase processing, known as sAPP,
which show that apoE-deficient mice display a distinctalso displays plasticity-promoting properties. This sAPP
impairment of reactive synaptogenesis (Masliah et al.,fragment is released from neurons in response to electri-
1996; Teter et al., 1999). Individual apoE alleles havecal activity and induces neurite outgrowth, experience-
differential impacts on plasticity. Thus, the e4 allele,related synaptogenesis, and LTP (Roch et al., 1994;
which is a major risk factor for AD, inhibits neurite growthHuber et al., 1997; Ishida et al., 1997; Mattson, 1997).
and dendritic plasticity, whereas the e3 allele promotesIn contrast to full-length AbPP and sAPP, the Ab frag-
these processes (Nathan et al., 1994; Arendt et al., 1997).ment of amyloid, especially its ªlongº form, is neurotoxic
Estrogen and Plasticityand inhibits axonal sprouting as well as LTP (Roher et
Estrogen replacement in postmenopausal women de-al., 1991; Lambert et al., 1998). Trisomy 21 and the AD-
creases the risk of developing AD (Kawas et al., 1997).causing genetic mutations of AbPP may thus interfere
Estrogens promote axonal and dendritic plasticity in thewith neural plasticity because they shift the balance of
limbic neurons of male as well as female brains (FerreiraAbPP processing toward the longer and more neuro-
and Caceres, 1991; Lorenzo et al., 1992; Woolley et al.,toxic forms of Ab (Almkvist et al., 1997; Hardy, 1997).
1996; McEwen et al., 1997; Teter et al., 1999). In femaleThe dendritic atrophy and synaptic rarefaction reported
mice, ovariectomy severely impairs the reactive hippo-
in trisomy 21 may reflect such an impairment of compen-
campal synaptogenesis that follows entorhinal damage.
satory neuroplasticity (Takashima et al., 1989). Further-
This effect is reversed by estrogen replacement (Stone
more, transgenic mice overexpressing one of the AD- et al., 1998). Postmenopausal estrogen deficiency may
causing mutations of AbPP show decreased synaptic thus suppress the potential for neuroplasticity.
and dendritic density in the dentate gyrus of the hippo- Age and Plasticity
campal formation, a reduced ability for compensatory The single most important risk factor for AD is age.
synaptogenesis in response to injury, impaired LTP, and Age influences both reactive and experience-dependent
a corresponding impairment of spatial working memory plasticity. Thus, reactive synaptogenesis in response
(Games et al., 1995; Masliah et al., 1995; Chapman et to complex experience, compensatory synaptogenesis
al., 1999). following injury, and the ability to sustain the effects of
Presenilins and Plasticity LTP are all diminished or slowed as a consequence of
Presenilin genes are homologous to the C. elegans sel- age (Scheff et al., 1980; Mori, 1993; Lanahan et al., 1997).
12 gene, which facilitates the activity of lin-12, a member Indirect evidence based on the examination of the cere-
of the Notch family. Notch is a critical protein involved brospinal fluid (CSF) suggests that aging may also shift
in neurogenesis and cell fate decisions in the developing the complex balance of AbPP metabolism away from
nervous system. The sel-12 mutant phenotype in C. the potentially neurotrophic products of a secretase
elegans can be rescued by normal human PS1 but not by processing and toward the production of neurotoxic
its AD-causing mutants, suggesting that such mutations moieties containing the intact Ab fragment (Palmert et
may interfere with putative Notch-related functions of al., 1990; van Gool et al., 1994). Age interacts with other
PS1 (Levitan et al., 1996). Furthermore, the expression variables that influence neuroplasticity. For example,
of an AD-causing mutant of PS1 causes a depression the age-related loss of synaptic and dendritic density
of nerve growth factor± (NGF-) induced neurite out- becomes substantially more intensified in apoE-defi-
growth in PC12 cells (Furukawa et al., 1998). The AD- cient mice (Masliah et al., 1996).
causing mutations of PS1 may also interfere with the
stabilization and degradation of b-catenin, a protein Speculations on the Linkage between a High
thought to play a critical role in the formation and mainte- Plasticity Burden and AD Neuropathology
nance of synaptic junctions, although the exact nature All AD-promoting factors are likely to perturb processes
that normally facilitate neuroplasticity. The hypothesisof this relationship appears to vary according to the
Review
525
in this section is based on the assumption that the resul- to cope with the loss of inputs from limbic±paralimbic
neurons and would also need to remodel axonal endingstant barriers to neuroplasticity occur at downstream
dendritic and synaptic sites and that they trigger a reac- to cope with the loss of synaptic sites at their limbic
targets. This would cause a ªverticalº expansion of thetive (or compensatory) upstream intensification of plas-
ticity-related perikaryal activity. In other words, AD-pro- disease during which the neurofibrillary degeneration
(and eventually cellular death) would spread centrifu-moting factors create a setting where neurons must
work harder to meet neuroplasticity needs at their axo- gally from limbic±paralimbic areas to association neo-
cortex, in keeping with the pattern shown in Figure 1.nal and dendritic terminals. Over many years, such com-
pensatory processes would lead to chronically high and In support of this scenario, tangle-bearing hippocam-
pal neurons show more extensive dendritic trees thaneventually unsustainable levels of plasticity-related cel-
lular activity. immediately adjacent tangle-free neurons, suggesting
that NFT formation may be accompanied (or preceded)In vivo and in vitro experiments show that high levels
of neuroplasticity tend to be associated with the in- by increased plasticity (Gertz et al., 1990). Furthermore,
tau mRNA is increased in the hippocampus (but notcreased expression and phosphorylation of tau (Buscig-
lio et al., 1987; Viereck et al., 1989; Trojanowski et al., in the visual cortex or cerebellum) of patients with AD
(Barton et al., 1990). The initial stages of AD are also1993; Brion et al., 1994; Black et al., 1996; Lovestone
and Reynolds, 1997). For example, the olfactory bulb of associated with increased tau in the CSF (Galasko et
al., 1997), suggesting that an upregulation of this proteinthe adult rat, a region that continues to show very active
neuroplasticity, expresses particularly high levels of the occurs at a time when the NFT are undergoing a steep
increase in density and distribution.more extensively phosphorylated, fetal forms of tau
(Viereck et al., 1989; Lovestone and Reynolds, 1997). Animal experiments show that injury- and denerva-
tion-induced neuroplasticity can also lead to an upregu-Furthermore, transfected PC12 cells overexpressing tau
extend neurites more rapidly, and neurite extension in lation of AbPP (Banati et al., 1993; Wallace et al., 1993;
Beeson et al., 1994; Chauvet et al., 1997). Fimbria±fornixresponse to NGF is associated with a 10- to 20-fold
induction of tau (Drubin et al., 1985; Esmaeli-Azad et lesions in adult rats, for example, elicit a marked accu-
mulation of AbPP immunoreactivity in the denervatedal., 1994). In the course of the processes that lead to AD,
a chronically high demand for plasticity-related activity areas within the hippocampus (Beeson et al., 1994).
Such reactive AbPP accumulation may be quite selec-could thus upregulate the expression of tau, favor its
phosphorylation, and potentially promote the polymer- tive. In the case of the fimbria±fornix lesions, it seems
to occur predominantly in the CA1 region but not in theization of tau into NFT. The NFT produced by such a
sequence of events would initially appear within limbic± dentate gyrus (Beeson et al., 1994). In the course of
events leading to AD, an initial upregulation of AbPPparalimbic neurons, because these neurons have the
highest baseline levels of plasticity and would thus have would be expected to occur at sites of maximal plasticity
burden, namely in limbic±paralimbic areas and their axo-the highest exposure to compensatory upregulations of
plasticity-related cellular activity. nal projection targets. This AbPP would then be pro-
cessed into the sAPP and Ab moieties, giving rise toThe resultant cytoskeletal dysfunction in these limbic±
paralimbic neurons would eventually lead to a degenera- complex combinations of neurotrophic and neurotoxic
effects. The released Ab would first have a soluble formtion of their dendrites and a loss of their synapses at
axonal projection targets. The adjacent limbic and para- and would diffuse within the extracellular fluid in the
form of 10±100 kDa monomers and oligomers (Kuo et al.,limbic neurons (many of which share the same connec-
tivity patterns) would then face at least two additional 1996). Upon exceeding local concentration thresholds,
this Ab would be expected to form fibrils and condenseplasticity demands: (1) more reactive synaptogenesis at
their projection targets, in order to replace the synapses into initially inert diffuse plaques that would eventually
mature into neurotoxic structures. The formation oforiginally provided by the degenerated axons of adja-
cent NFT-containing neurons; and (2) more local den- plaques by local condensation after the diffusion of the
amyloid from sites of upregulation, the fact that thesedritic remodeling to receive the synapses that can no
longer be accommodated by the degenerated dendrites sites can overlap with NFT-prone limbic±paralimbic neu-
rons or their widespread projection targets, the apparentof adjacent NFT-containing neurons. Because of the
downstream barriers to plasticity, these attempts at re- regional selectivity of plasticity-induced AbPP accumu-
lation, and the initial inertness of the deposited amyloidactive remodeling would be relatively ineffective and
would induce an excessive upstream intensification of may explain why plaques do not mirror the distribution
of the NFT, and why they do not necessarily display aplasticity-related neuronal activity, eventually leading to
the formation of NFT in these additional neurons. This spatial and temporal distribution that fits the clinical
features of the dementia.sequence of events would promote the ªhorizontalº
spread of NFT within the tightly interconnected compo- The premature development of NFT and Ab deposits
in the brains of ex-boxers provides further circumstantialnents of limbic±paralimbic cortices and would initiate
the relatively slow ªlimbicº phase of disease progression support for the contention that a heightened state of
neuroplasticity (in this case, injury-induced) can trigger(from the ªLow Limbicº to the ªHigh Limbicº stages in
Figure 1). the neuropathological changes of AD (Tokuda et al.,
1991; Geddes et al., 1996). This is perhaps why headThe loss of dendrites and synapses belonging to lim-
bic±paralimbic neurons would eventually increase the injury and stroke have both been implicated as risk fac-
tors for AD (Salib and Hillier, 1997; Snowdon et al., 1997).plasticity burden of the association cortices with which
they are reciprocally interconnected. These association However, such relationships are probably relevant only
when the injury is widespread and chronic, and when itareas would need to accelerate dendritic remodeling
Neuron
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Figure 2. Multiple Factors Increase the Neu-
roplasticity Burden
Eventually, the excessive neuroplasticity bur-
den triggers plaque and NFT formation. AD
is said to exist when the density of both of
these histopathological markers exceeds a
certain threshold and when they are accom-
panied by dementia. Abbreviations: Ab, b am-
yloid; AbPP, b amyloid precursor protein;
ApoE, apolipoprotein E; NFT, neurofibrillary
tangle; PS, presenilin.
occurs on a background of additional factors that erect threshold and duration needed to trigger the events that
lead to AD.downstream barriers to neuroplasticity. Otherwise, all
neuronal diseases would eventually lead to AD pa- The biological capacity for plasticity decreases with
age, explaining why age is the single most importantthology.
A severe depletion of cortical cholinergic innervation and universal risk factor for AD. According to this formu-
lation, the AD of old age may not be a disease at all butis one of the most consistent features in the neuropa-
thology of AD (Geula and Mesulam, 1999). The choliner- the inevitable manifestation of a failure to keep up with
the increasingly more burdensome work of plasticity.gic innervation of the cerebral cortex arises from the
nucleus basalis of Meynert, a limbic structure that main- Other factors such as trisomy 21, the e4 allele of apoE,
estrogen deficiency, head trauma, and the AD-relatedtains an unusually high level of plasticity into late adult-
hood (Arendt et al., 1995). Neurons of the nucleus basalis mutations of AbPP, PS1, and PS2 accelerate the time
course of the events leading to AD by increasing theare consequently among the very first cells of the brain
to display an accumulation initially of hyperphosphory- burden of neuroplasticity (Figure 2). The fact that all of
these factors operate through a common downstreamlated tau and then of NFT (Mesulam, 1996). Numerous
experiments have shown that cholinergic neurotrans- mechanism helps to explain how the numerous geno-
types of AD cause an identical clinical and neuropatho-mission plays an essential role in supporting reactive
and experience-induced synaptic reorganization in the logical disease phenotype. Genetic mutations do not
really cause AD; they simply accelerate the temporalcerebral cortex (Baskerville et al., 1997; Kilgard and
Merzenich, 1998; Zhu and Waite, 1998). Furthermore, course of events that lead to plasticity failure and there-
fore lower the age at which the pathological processcortical cholinergic innervation also promotes the a se-
cretase pathway and therefore the release of the neuro- begins to gather momentum. The advanced cognitive
and mnemonic activities of the human brain imposetrophic sAPP moieties (Nitsch et al., 1992). The early loss
of cholinergic innervation in AD could thus contribute to a very high plasticity burden. The combination of this
property with a long life span may endow the humanthe acceleration of the pathological process by further
jeopardizing the potential for neuroplasticity in the cere- brain with its unique susceptibility to AD.
The first wave of AD therapy has aimed to reversebral cortex, both directly and through changes in AbPP
metabolism. the depletion of cortical cholinergic neurotransmission.
Subsequent strategies may aim to inhibit tau polymer-
ization and Ab formation. For reasons that have beenConclusions
described above, such interventions may not be entirelyªNeuroplasticityº is a generic term referring to pro-
successful unless the underlying plasticity failure is alsocesses of vital importance for the structural upkeep of
addressed. The proposed role of plasticity suggests thatthe brain and for the functional adaptation of the organ-
important insights related to the pathophysiology andism to the environment. The evidence reviewed above
prevention of AD may come from the fields of develop-leads to the hypothesis that the remote initiators of AD
mental biology. One of the most important goals will bemay be traced to factors that erect physiological barriers
to understand the processes that influence plasticity into the downstream manifestations of neuroplasticity,
the adult human brain and to determine whether theirand that the NFT and AP represent independent by-
vulnerability to aging and to the other AD-causing fac-products of initially compensatory but eventually exces-
tors can be modified.sive and maladaptive plasticity-related cellular activity.
The exceedingly complex events associated with neu-
roplasticity are influenced by multiple genetic and envi-
Acknowledgmentsronmental factors. Consequently, a large number of vari-
ables can determine the ease (or difficulty) with which Supported in part by an Alzheimer's Disease Center grant AG13854
the neuroplasticity demands are met and also the time at from the National Institute on Aging and grant NS20285 from the
National Institute of Neurological Disorders and Stroke.which perturbations of neuroplasticity reach the critical
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